(1S,3'S,4R,4'S,5'S,6S,7R,8R,12R,13R,14R,16R)-14-[(2S,3R,4S,5S)-3-[(2S,3R,4R,5S,6S)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3',16-dihydroxy-7-(hydroxymethyl)-5',13-dimethyl-4'-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-2(9),18-diene-6,2'-oxane]-3-one

Details

Top
Internal ID bb4f2928-28bf-46ab-8a53-16c85323eb0a
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name (1S,3'S,4R,4'S,5'S,6S,7R,8R,12R,13R,14R,16R)-14-[(2S,3R,4S,5S)-3-[(2S,3R,4R,5S,6S)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3',16-dihydroxy-7-(hydroxymethyl)-5',13-dimethyl-4'-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-2(9),18-diene-6,2'-oxane]-3-one
SMILES (Canonical) CC1COC2(C(C3C(O2)C(=O)C4=C3CCC5C4CC=C6C5(C(CC(C6)O)OC7C(C(C(CO7)O)OC8C(C(C(CO8)O)O)O)OC9C(C(C(C(O9)C)O)OC2C(C(CO2)(CO)O)O)O)C)CO)C(C1OC1C(C(C(C(O1)C)O)O)O)O
SMILES (Isomeric) C[C@H]1CO[C@]2([C@H]([C@H]3[C@@H](O2)C(=O)C4=C3CC[C@@H]5[C@@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O[C@H]7[C@@H]([C@H]([C@H](CO7)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O[C@H]2[C@@H]([C@](CO2)(CO)O)O)O)C)CO)[C@H]([C@H]1O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O
InChI InChI=1S/C53H80O28/c1-17-12-73-53(44(67)39(17)77-47-37(65)35(63)31(59)18(2)74-47)25(11-54)30-23-7-8-24-22(29(23)34(62)41(30)81-53)6-5-20-9-21(56)10-28(51(20,24)4)76-49-43(40(27(58)14-71-49)78-46-36(64)33(61)26(57)13-70-46)80-48-38(66)42(32(60)19(3)75-48)79-50-45(68)52(69,15-55)16-72-50/h5,17-19,21-22,24-28,30-33,35-50,54-61,63-69H,6-16H2,1-4H3/t17-,18-,19-,21+,22-,24+,25-,26+,27-,28+,30-,31-,32-,33-,35+,36+,37+,38+,39-,40-,41+,42+,43+,44-,45-,46-,47-,48-,49-,50-,51-,52+,53-/m0/s1
InChI Key LTWMDDYNUKKCPA-YOTHLHBZSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C53H80O28
Molecular Weight 1165.20 g/mol
Exact Mass 1164.48361189 g/mol
Topological Polar Surface Area (TPSA) 431.00 Ų
XlogP -7.00
Atomic LogP (AlogP) -6.45
H-Bond Acceptor 28
H-Bond Donor 15
Rotatable Bonds 12

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,3'S,4R,4'S,5'S,6S,7R,8R,12R,13R,14R,16R)-14-[(2S,3R,4S,5S)-3-[(2S,3R,4R,5S,6S)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3',16-dihydroxy-7-(hydroxymethyl)-5',13-dimethyl-4'-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-2(9),18-diene-6,2'-oxane]-3-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8294 82.94%
Caco-2 - 0.8779 87.79%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.8220 82.20%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8284 82.84%
OATP1B3 inhibitior + 0.8670 86.70%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior + 0.9499 94.99%
P-glycoprotein inhibitior + 0.7420 74.20%
P-glycoprotein substrate + 0.7377 73.77%
CYP3A4 substrate + 0.7510 75.10%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8843 88.43%
CYP3A4 inhibition - 0.9196 91.96%
CYP2C9 inhibition - 0.9244 92.44%
CYP2C19 inhibition - 0.9343 93.43%
CYP2D6 inhibition - 0.9378 93.78%
CYP1A2 inhibition - 0.9172 91.72%
CYP2C8 inhibition + 0.8074 80.74%
CYP inhibitory promiscuity - 0.9444 94.44%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5179 51.79%
Eye corrosion - 0.9902 99.02%
Eye irritation - 0.9028 90.28%
Skin irritation + 0.5497 54.97%
Skin corrosion - 0.9408 94.08%
Ames mutagenesis - 0.5424 54.24%
Human Ether-a-go-go-Related Gene inhibition + 0.7942 79.42%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.5052 50.52%
skin sensitisation - 0.9231 92.31%
Respiratory toxicity + 0.7444 74.44%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.5250 52.50%
Nephrotoxicity + 0.7757 77.57%
Acute Oral Toxicity (c) I 0.4770 47.70%
Estrogen receptor binding + 0.8451 84.51%
Androgen receptor binding + 0.7644 76.44%
Thyroid receptor binding + 0.6216 62.16%
Glucocorticoid receptor binding + 0.7464 74.64%
Aromatase binding + 0.6156 61.56%
PPAR gamma + 0.8216 82.16%
Honey bee toxicity - 0.6073 60.73%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity + 0.9416 94.16%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.26% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 98.99% 95.93%
CHEMBL1293249 Q13887 Kruppel-like factor 5 97.92% 86.33%
CHEMBL3137262 O60341 LSD1/CoREST complex 96.89% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.35% 95.56%
CHEMBL2581 P07339 Cathepsin D 93.31% 98.95%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 93.16% 94.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.67% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.47% 89.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 90.55% 100.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.82% 95.89%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 89.13% 97.14%
CHEMBL253 P34972 Cannabinoid CB2 receptor 89.12% 97.25%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 89.00% 92.88%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 88.46% 91.24%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 88.06% 91.07%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.89% 99.23%
CHEMBL241 Q14432 Phosphodiesterase 3A 87.82% 92.94%
CHEMBL2243 O00519 Anandamide amidohydrolase 85.32% 97.53%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.97% 95.89%
CHEMBL3714130 P46095 G-protein coupled receptor 6 82.88% 97.36%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.92% 96.00%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.96% 96.61%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Trillium tschonoskii

Cross-Links

Top
PubChem 163098923
LOTUS LTS0174973
wikiData Q105157228